Tryptamine Therapeutics
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Industry Lists
Public Companies - non WATryptamine Therapeutics listed in 2024 through the reverse takeover of Exopharm. Tryptamine Therapeutics is a clinical-stage biotechnology company focused on the development of an IV infusion of psilocin (the active metabolite of psilocybin) which addresses many of the current limitations associated with orally administered psilocybin used by the majority of competitors in the field. Tryp’s lead programs are designed to address neuropsychiatric disorders through the therapeutic dosing of synthetic psilocybin and IV infused psilocin in conjunction with psychotherapy.
Contact Details
C/o Bio101 Financial Advisory Pty Ltd Suite 201, 697 Burke Road, CAMBERWELL VIC 3124
Lists and Charts
Share price
Closing price for the last 90 trading days
Powered by Morningstar ®
Total Shareholder Return as at 30/08/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 85th | Tryptamine Therapeutics | 133% | -45% |
1746 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 893rd |  | Tryptamine Therapeutics | $3.4m |
1333 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Company Activity
| NEW ROLE: Chris Ntoumenopoulos, Non-Executive Director | 08 Aug 2024 |
| NEW ROLE: Mark Davies, Non-Executive Chairman, Non-Executive Director | 08 Aug 2024 |
| ECM DEAL: New deal has been added | 22 Jul 2024 |
| UPDATED: Public Companies - non WA list | 05 Jul 2024 |
| NEW ROLE: Clarke Barlow, Non-Executive Director | 17 Nov 2023 |
| RANKING: 918 Down from 701 in Public Companies - non WA list | 02 Oct 2023 |
| ECM DEAL: New deal has been added | 29 Sep 2023 |
| NEW ROLE: Michael West, | 03 Nov 2022 |
